Kevin Sabet, CEO of Smart Approaches to Marijuana, discusses a class-action suit against Chicago cannabis companies for allegedly selling products with mendacious aesculapian benefits connected 'America's Newsroom.'
Dana Perino reports connected a class-action suit filed against 3 Chicago-based cannabis companies for allegedly selling products nether mendacious wellness claims. Kevin Sabet, CEO of Smart Approaches to Marijuana, discusses the suit, emphasizing user extortion and the public's close to cognize astir imaginable broadside effects of high-potency THC, specified arsenic psychosis and schizophrenia. This follows the Trump administration's reclassification of marijuana to a Schedule 3 substance.










English (CA) ·
English (US) ·
Spanish (MX) ·